We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+5.88%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$21.3B
AUM Growth
-$547M
Cap. Flow
-$8.07B
Cap. Flow %
-37.88%
Top 10 Hldgs %
16.57%
Holding
1,618
New
335
Increased
76
Reduced
310
Closed
386

Sector Composition

Rank Sector Weight
1 Technology 13.17%
2 Financials 12.22%
3 Healthcare 8.73%
4 Consumer Discretionary 5.35%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTFW
851
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Warrant
ENTFW
$11.3K ﹤0.01%
+600,000
New +$24.2K
PLMJW
852
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
$11K ﹤0.01%
250,000
CDAQW
853
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$10.9K ﹤0.01%
166,666
PEGRW
854
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$10.8K ﹤0.01%
250,000
LANV.WS
855
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$10.5K ﹤0.01%
+35,000
New +$9.18K
HORIW
856
DELISTED
Emerging Markets Horizon Corp. Warrants
HORIW
$10.3K ﹤0.01%
+372,761
New +$16.8K
OPTXW icon
857
Syntec Optics Holdings Warrant
OPTXW
$13.4M
$10.2K ﹤0.01%
+250,000
New +$8.63K
HCMAW
858
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$10.2K ﹤0.01%
+625,000
New +$18.7K
SHAP.WS
859
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$10.1K ﹤0.01%
+250,000
New +$12K
AONCW
860
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$10K ﹤0.01%
156,250
CNDA.WS
861
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$10K ﹤0.01%
92,316
FTIIW
862
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$10K ﹤0.01%
+500,000
New +$11.8K
TCOA.WS
863
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$10K ﹤0.01%
+250,000
New +$14.6K
GSDWW
864
DELISTED
Global Systems Dynamics, Inc. Warrant
GSDWW
$10K ﹤0.01%
200,000
ATEK.WS
865
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$9.95K ﹤0.01%
+250,000
New +$11.7K
ENCPW
866
DELISTED
Energem Corp Warrant
ENCPW
$9.88K ﹤0.01%
125,000
MNTN.WS
867
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$9.44K ﹤0.01%
+625,000
New +$23.4K
AAC.WS
868
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$9.33K ﹤0.01%
20,000
OCEAW
869
DELISTED
Ocean Biomediacal, Inc. Warrants
OCEAW
$9.22K ﹤0.01%
62,500
GATEW
870
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$9.13K ﹤0.01%
228,160
BACA.WS
871
DELISTED
Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50
BACA.WS
$9.13K ﹤0.01%
250,000
CITEW
872
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$9.01K ﹤0.01%
+134,701
New +$7.81K
AERTW
873
Aeries Technology Warrant
AERTW
$8.89K ﹤0.01%
289,507
SPWRW
874
SunPower Inc Warrants
SPWRW
$947K
$8.5K ﹤0.01%
42,500
EBACW
875
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
$8.33K ﹤0.01%
33,333

Similar funds

Calamos Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Calamos Advisors held 1,618 positions worth $21.3B, down 2.5% from $21.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Calamos Advisors withdrew a net $8.07B in Q4 2022, closing 386 positions and reducing 310 holdings. Its most notable exit was DTE Energy Company 2019 Corporate Units, an estimated $51.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Vanguard S&P 500 ETF worth $471M.

  • Calamos Advisors's largest Q4 2022 buy was Vanguard S&P 500 ETF: 1,340,747 shares worth $471M.
  • Calamos Advisors added most to T-Mobile US in Q4 2022, an estimated $24.1M increase.
  • Calamos Advisors's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • Calamos Advisors fully exited DTE Energy Company 2019 Corporate Units in Q4 2022, selling an estimated $51.3M.
  • Calamos Advisors's ten largest holdings make up 17% of its $21.3B portfolio in Q4 2022.
  • Calamos Advisors opened 335 new positions and closed 386 in Q4 2022.
  • Calamos Advisors's portfolio value fell 2.5% quarter-over-quarter to $21.3B.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.